Cardio-Oncology: Role of Echocardiography

Progress in Cardiovascular Diseases

Volumn 57, Issue 1, 2014, Pages 10-18

  Villarraga, Hector R ^a   Herrmann, Joerg ^a   Nkomo, Vuyisile T ^a  

^a MAYO CLINIC   (United States)

Author keywords

Breast cancer; Cardio oncology; Lymphoma; Radiotherapy; Strain

Indexed keywords

ANTHRACYCLINE DERIVATIVE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERICARDIAL DISEASE; SOLID TUMOR; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

BREAST CANCER; CARDIO-ONCOLOGY; LYMPHOMA; RADIOTHERAPY; STRAIN;

ANIMALS; CARDIOLOGY; ECHOCARDIOGRAPHY; HEART NEOPLASMS; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS;

EID: 84904916682     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.05.002     Document Type: Article

References (72)

1. Lotrionte M., Biondi-Zoccai G., Abbate A., et al. Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. Am J Cardiol 2013, 112:1980-1984.
2. Swain S.M., Whaley F.S., Ewer M.S. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 2003, 97:2869-2879.
3. Du X.L., Xia R., Liu C.C., et al. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer. Cancer 2009, 115:5296-5308.
4. Ewer M.S., Lippman S.M. Type ii chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol 2005, 23:2900-2902.
5. Cardinale D., Colombo A., Lamantia G., et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 2010, 55:213-220.
6. Fallah-Rad N., Lytwyn M., Fang T., Kirkpatrick I., Jassal D.S. Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy. J Cardiovasc Magn Reson 2008, 10:5.
7. Ferrans V.J. Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treat Rep 1978, 62:955-961.
8. Shan K., Lincoff A.M., Young J.B. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996, 125:47-58.
9. Von Hoff D.D., Layard M.W., Basa P., et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979, 91:710-717.
10. van der Pal H.J., van Dalen E.C., van Delden E., et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol 2012, 30:1429-1437.
11. Lemmens K., Doggen K., De Keulenaer G.W. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: Implications for therapy of heart failure. Circulation 2007, 116:954-960.
12. Ewer M.S., Ewer S.M. Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat Rev Cardiol 2010, 7:564-575.
13. Perez E.A., Koehler M., Byrne J., Preston A.J., Rappold E., Ewer M.S. Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials. Mayo Clin Proc 2008, 83:679-686.
14. Choueiri T.K., Mayer E.L., Je Y., et al. Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J Clin Oncol 2011, 29:632-638.
15. Hawkes E.A., Okines A.F., Plummer C., Cunningham D. Cardiotoxicity in patients treated with bevacizumab is potentially reversible. J Clin Oncol 2011, 29:e560-e562.
16. Hariharan S., Lowry S. Cardiotoxicity associated with sunitinib. Lancet 2008, 371:1244-1245. [author reply 1245].
17. van Leeuwen-Segarceanu E.M., Bos W.J., Dorresteijn L.D., et al. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease. Cancer Treat Rev 2011, 37:391-403.
18. Stewart J.R., Fajardo L.F., Gillette S.M., Constine L.S. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995, 31:1205-1211.
19. Veinot J.P., Edwards W.D. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 1996, 27:766-773.
20. Seemann I., Gabriels K., Visser N.L., et al. Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature. Radiother Oncol 2012, 103:143-150.
21. Marks L.B., Yu X., Prosnitz R.G., et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 2005, 63:214-223.
22. Mulrooney D.A., Yeazel M.W., Kawashima T., et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort. BMJ 2009, 339:b4606.
23. Berry G.J., Jorden M. Pathology of radiation and anthracycline cardiotoxicity. Pediatr Blood Cancer 2005, 44:630-637.
24. McGowan J.H., Cleland J.G. Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J 2003, 146:388-397.
25. Curtis J.P., Sokol S.I., Wang Y., et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 2003, 42:736-742.
26. Nahar T., Croft L., Shapiro R., et al. Comparison of four echocardiographic techniques for measuring left ventricular ejection fraction. Am J Cardiol 2000, 86:1358-1362.
27. Thomson H.L., Basmadjian A.J., Rainbird A.J., et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. J Am Coll Cardiol 2001, 38:867-875.
28. Malm S., Frigstad S., Sagberg E., Larsson H., Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2004, 44:1030-1035.
29. Walker J., Bhullar N., Fallah-Rad N., et al. Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. J Clin Oncol 2010, 28:3429-3436.
30. Ewer M.S., Lenihan D.J. Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?. J Clin Oncol 2008, 26:1201-1203.
31. Ewer M.S., Ali M.K., Mackay B., et al. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving adriamycin. J Clin Oncol 1984, 2:112-117.
32. Pudil R., Horacek J.M., Strasova A., Jebavy L., Vojacek J. Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines. Exp Oncol 2008, 30:160-162.
33. Ganame J., Claus P., Eyskens B., et al. Acute cardiac functional and morphological changes after anthracycline infusions in children. Am J Cardiol 2007, 99:974-977.
34. Xu Y H, J, Pellikka P, Ansell S, Cha S, Villarraga HR. Early changes in 2d-speckle tracking echocardiography may predict a decrease in left ventricular ejection fraction in lymphoma patients undergoing anthracycline chemotherapy. Journal of the American Society of Echocardiography forthcoming;26:B52.
35. Sandhu N., Spoon J., Herrmann J., Pellikka P.A., Villarraga H. Two dimensional speckle tracking echocardiography predicts preclinical cardiotoxicity in breast cancer patients. J Am Coll Cardiol 2014, 63:A199.
36. Fine N.M., Shah A.A., Han I.Y., et al. Left and right ventricular strain and strain rate measurement in normal adults using velocity vector imaging: an assessment of reference values and intersystem agreement. Int J Cardiovasc Imaging 2013 Mar, 29(3):571-580.
37. Risum N., Ali S., Olsen N.T., et al. Variability of global left ventricular deformation analysis using vendor dependent and independent two-dimensional speckle-tracking software in adults. J Am Soc Echocardiogr 2012 Nov, 25(11):1195-1203.
38. Carasso S., Biaggi P., Rakowski H., et al. Velocity vector imaging: standard tissue-tracking results acquired in normals-the VVI-STRAIN study. J Am Soc Echocardiogr 2012, 25:543-552.
39. Manovel A., Dawson D., Smith B., Nihoyannopoulos P. Assessment of left ventricular function by different speckle-tracking software. Eur J Echocardiogr 2010, 11:417-421.
40. Marwick T.H., Leano R.L., Brown J., et al. Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range. JACC Cardiovasc Imaging 2009, 2:80-84.
41. Takigiku K., Takeuchi M., Izumi C., et al. Normal range of left ventricular 2-dimensional strain. Circ J 2012, 76(11):2623-2632.
42. Abraham T., Kass D., Tonti G., et al. Imaging cardiac resynchronization therapy. JACC Cardiovasc Imaging 2009, 2:486-497.
43. Jurcut R., Wildiers H., Ganame J., et al. Strain rate imaging detects early cardiac effects of pegylated liposomal doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr 2008, 21:1283-1289.
44. Fallah-Rad N., Walker J.R., Wassef A., et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol 2011, 57:2263-2270.
45. Poterucha J.T., Kutty S., Lindquist R.K., Li L., Eidem B.W. Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr 2012, 25:733-740.
46. Sawaya H., Sebag I.A., Plana J.C., et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol 2011, 107:1375-1380.
47. Sawaya H., Sebag I.A., Plana J.C., et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 2012, 5:596-603.
48. Stoodley P.W., Richards D.A., Hui R., et al. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. Eur J Echocardiogr 2011, 12:945-952.
49. Neilan T.G., Jassal D.S., Perez-Sanz T.M., et al. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 2006, 27:1868-1875.
50. Cheung Y.F., Hong W.J., Chan G.C., Wong S.J., Ha S.Y. Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy. Heart 2010, 96:1137-1141.
51. Ho E., Brown A., Barrett P., et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 2010, 96:701-707.
52. Tsai H.R., Gjesdal O., Wethal T., et al. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy. Am J Cardiol 2011, 107:472-477.
53. Yusuf S.W., Sami S., Daher I.N. Radiation-induced heart disease: a clinical update. Cardiol Res Pract 2011, 2011:317659.
54. Wang Z.J., Reddy G.P., Gotway M.B., Yeh B.M., Hetts S.W., Higgins C.B. CT and MR imaging of pericardial disease. Radiographics 2003, 23. [Spec No:S167-180].
55. Nagueh S.F., Appleton C.P., Gillebert T.C., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009, 10:165-193.
56. Reuss C.S., Wilansky S.M., Lester S.J., et al. Using mitral 'annulus reversus' to diagnose constrictive pericarditis. Eur J Echocardiogr 2009, 10:372-375.
57. Seidman A., Hudis C., Pierri M.K., et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002, 20:1215-1221.
58. Erven K., Jurcut R., Weltens C., et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. Int J Radiat Oncol Biol Phys 2011, 79:1444-1451.
59. Edvardsen T., Helle-Valle T., Smiseth O.A. Systolic dysfunction in heart failure with normal ejection fraction: speckle-tracking echocardiography. Prog Cardiovasc Dis 2006, 49:207-214.
60. Matshela M.R., Blauwet L.A., Pellikka P.A., Oh J.K., Villarraga H.R. Radiation-induced constrictive pericarditis(r-cp) with normal left ventricular ejection fraction is associated with lower global and regional myocardial mechanics compared to non-radiation-induced constrictive-pericarditis(cp). Circulation 2013, 128:A18995.
61. Heidenreich P.A., Hancock S.L., Vagelos R.H., Lee B.K., Schnittger I. Diastolic dysfunction after mediastinal irradiation. Am Heart J 2005, 150:977-982.
62. Handa N., McGregor C.G., Danielson G.K., et al. Valvular heart operation in patients with previous mediastinal radiation therapy. Ann Thorac Surg 2001, 71:1880-1884.
63. Lund M.B., Ihlen H., Voss B.M., et al. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart 1996, 75:591-595.
64. Heidenreich P.A., Schnittger I., Strauss H.W., et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 2007, 25:43-49.
65. Hamza A., Tunick P.A., Kronzon I. Echocardiographic manifestations of complications of radiation therapy. Echocardiography 2009, 26:724-728.
66. Hering D., Faber L., Horstkotte D. Echocardiographic features of radiation-associated valvular disease. Am J Cardiol 2003, 92:226-230.
67. Malanca M., Cimadevilla C., Brochet E., Iung B., Vahanian A., Messika-Zeitoun D. Radiotherapy-induced mitral stenosis: a three-dimensional perspective. Int J Cardiovasc Imaging 2010 Jan, 23(1):108.e1-108.e2.
68. Forman M.B., Virmani R., Robertson R.M., Stone W.J. Mitral annular calcification in chronic renal failure. Chest 1984, 85:367-371.
69. Heidenreich P.A., Hancock S.L., Lee B.K., Mariscal C.S., Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 2003, 42:743-749.
70. Hull M.C., Morris C.G., Pepine C.J., Mendenhall N.P. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003, 290:2831-2837.
71. Heidenreich P.A., Kapoor J.R. Radiation induced heart disease: systemic disorders in heart disease. Heart 2009, 95:252-258.
72. Lancellotti P., Nkomo V.T., Badano L.P., et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: A report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2013, 14:721-740.